Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac in Great Toe Arthrodesis
NCT05054868Phase 1Unknown
- Sponsor
- MedStar Health Research Institute
- Start
- Apr 2020
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 1, randomised trial of ketorolac in postoperative pain, sponsored by MedStar Health Research Institute. Primary endpoints: Pain scores at 14 days and Quantitative pain management at 14 days. Status: unknown.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05054868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05054868.